These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 24973470)

  • 1. Role of oxidative stress versus lipids in monocrotaline-induced pulmonary hypertension and right heart failure.
    Farahmand F; Malik A; Sharma A; Bagchi AK; Singal PK
    Physiol Rep; 2021 Nov; 9(22):e15090. PubMed ID: 34816616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension.
    Rafikova O; Rafikov R; Kumar S; Sharma S; Aggarwal S; Schneider F; Jonigk D; Black SM; Tofovic SP
    Free Radic Biol Med; 2013 Mar; 56():28-43. PubMed ID: 23200808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.
    Ramiro-Diaz JM; Nitta CH; Maston LD; Codianni S; Giermakowska W; Resta TC; Gonzalez Bosc LV
    Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(9):L613-25. PubMed ID: 23475768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress.
    Chai Y; Gu X; Zhang H; Xu X; Chen L
    Aging (Albany NY); 2024 Mar; 16(6):5027-5037. PubMed ID: 38517365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol effectively prevents oxidative stress and stabilizes hypoxia-inducible factor-1 alpha (HIF-1α) in an animal model of global hypoxia.
    Kletkiewicz H; Wojciechowski MS; Rogalska J
    Sci Rep; 2024 Jul; 14(1):15952. PubMed ID: 38987284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development.
    Ahmed ASI; Blood AB; Zhang L
    Drug Discov Today; 2024 Jun; 29(6):104015. PubMed ID: 38719143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant Regulation of microRNA Between Multiple Experimental Models and Human Pulmonary Hypertension.
    Schlosser K; Taha M; Deng Y; Jiang B; Stewart DJ
    Chest; 2015 Aug; 148(2):481-490. PubMed ID: 25763574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-related biomarkers in pulmonary hypertension.
    Swaminathan AC; Dusek AC; McMahon TJ
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):663-73. PubMed ID: 25611885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension.
    Chettimada S; Gupte R; Rawat D; Gebb SA; McMurtry IF; Gupte SA
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L287-300. PubMed ID: 25480333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.
    Nozik-Grayck E; Woods C; Taylor JM; Benninger RK; Johnson RD; Villegas LR; Stenmark KR; Harrison DG; Majka SM; Irwin D; Farrow KN
    Am J Physiol Lung Cell Mol Physiol; 2014 Dec; 307(11):L868-76. PubMed ID: 25326578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.
    Montagnoli TL; da Silva JS; Sudo SZ; Santos AD; Gomide GF; de Sá MPL; Zapata-Sudo G
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases.
    Riou M; Alfatni A; Charles AL; Andrès E; Pistea C; Charloux A; Geny B
    J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32357474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study.
    Zhang X; Zhang X; Wang S; Luo J; Zhao Z; Zheng C; Shen J
    Can Respir J; 2018; 2018():3148259. PubMed ID: 29785232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Damage and Pulmonary Hypertension.
    Ranchoux B; Meloche J; Paulin R; Boucherat O; Provencher S; Bonnet S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin 1 protects astrocytes from oxidative stress by maintaining peroxiredoxin activity.
    Wang M; Zhu K; Zhang L; Li L; Zhao J
    Mol Med Rep; 2016 Mar; 13(3):2864-70. PubMed ID: 26846911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasudil reversed MCT-induced and chronic hypoxia-induced pulmonary hypertension by attenuating oxidative stress and inhibiting the expression of Trx1 and HIF-1α.
    Liu M; Wang Y; Zheng L; Zheng W; Dong K; Chen S; Zhang B; Li Z
    Respir Physiol Neurobiol; 2014 Sep; 201():38-46. PubMed ID: 24973470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
    Gupta N; Rashid J; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
    Mol Pharm; 2017 Mar; 14(3):830-841. PubMed ID: 28165252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
    Jiang H; Guan RJ; Wang HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):239-44. PubMed ID: 23879951
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.